As bispecific antibodies (bsAbs) continue to reshape therapeutic strategies, understanding how their structure influences production success is imperative. From asymmetric constructs to fragment-based designs, each format presents unique challenges and advantages in expression and purification. Researchers navigating this complex landscape need a clear reference to guide efficient design and manufacturing decisions.
Download this whitepaper to learn:
- Key production indicators, including manufacturability scores, recommended purification steps, and expected yields, across more than 70 bsAb formats
- How different bispecific antibody formats impact manufacturability, purification strategies, and production yields
- The advantages and trade-offs between symmetric, asymmetric, and fragment-based bsAb structures
